GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for beta-1,3-N-acetylglucosaminyltransferase radical fringe (Q6KFX9)

Analyse AlphaFold monomer V2.0 prediction for beta-1,3-N-acetylglucosaminyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q6KFX9
Type
protein
Length
362 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x6DAA77C4263E74E745cA9c4D8E291e57e8991Cf5
Molecule
Beta-1,3-N-acetylglucosaminyltransferase radical fringe
UniProt
Q6KFX9
Pockets
2 · best druggability 0.54

Structure

1 distinct chain · 40% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-1,3-N-acetylglucosaminyltransferase radical fringeprotein36240% helix, 13% strandQ6KFX9

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12020.540.7927empty
2850.330.7411empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.